HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kofidis, T. Articles by Robbins, R. C. Search for Related Content PubMed PubMed Citation Articles by Kofidis, T. Articles by Robbins, R. C. Related Collections Coronary disease

J Thorac Cardiovasc Surg 2004;128:571-578
© 2004 The American Association for Thoracic Surgery

Evolving Technology

Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle

^a Cardiothoracic Surgery/Falk Research Center, Stanford University Medical School, Stanford, Calif, USA
^b Department of Immunology, Stanford University Medical School, Stanford, Calif, USA
^c Division of Cardiovascular Medicine, Stanford University Medical School, Stanford, Calif, USA

Received for publication October 17, 2003; revisions received April 14, 2004; accepted for publication May 13, 2004.

^* Address for reprints: Theo Kofidis, MD, Cardiothoracic Surgery/Falk Research Center, 2nd Floor, Stanford University Medical School, 300 Pasteur Dr, Stanford, CA 94305 (E-mail: tkofidis{at}stanford.edu).

OBJECTIVES: Most tissue-engineering approaches to restore injured heart muscle result in distortion of left ventricular geometry. In the present study we suggest seeding embryonic stem cells in a liquid matrix for myocardial restoration.

METHODS: Undifferentiated green fluorescent protein–labeled mouse embryonic stem cells (2 x 10⁶) were seeded in Matrigel (B&D, Bedford, Mass). In a Lewis rat heterotopic heart transplant model an intramural left ventricular pouch was fashioned after ligation of the left anterior descending coronary artery. The liquid mixture (0.125 mL) was injected in the resulting infarcted area within the pouch and solidified within a few minutes after transplantation (37°C). Five recipient groups were formed: transplanted healthy hearts (group I), infarcted control hearts (group II), matrix recipients alone (group III), the study group that received matrix plus cells (group IV), and a group that received embryonic stem cells alone (group V). After echocardiography 2 weeks later, the hearts were harvested and stained for green fluorescent protein and cardiac muscle markers (connexin 43 and -sarcomeric actin).

RESULTS: The graft formed a sustained structure within the injured area and prevented ventricular wall thinning. The inoculated cells remained viable and expressed connexin 43 and -sarcomeric actin. Fractional shortening and regional contractility were better in animals that received bioartificial tissue grafts compared with control animals (infarcted, matrix only, and embryonic stem cells only: group I, 17.0% ± 3.5%; group II, 6.6% ± 2.1%; group III, 10.3% ± 2.2%; group IV, 14.5% ± 2.5%; and group V, 7.8% ± 1.8%).

CONCLUSIONS: Liquid bioartificial tissue containing embryonic stem cells constitutes a powerful new approach to restoring injured heart muscle without distorting its geometry and structure.

This article has been cited by other articles:

				J. Yu, K. L. Christman, E. Chin, R. E. Sievers, M. Saeed, and R. J. Lee Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 180 - 187. [Abstract] [Full Text] [PDF]

				H. Sekine, T. Shimizu, K. Hobo, S. Sekiya, J. Yang, M. Yamato, H. Kurosawa, E. Kobayashi, and T. Okano Endothelial Cell Coculture Within Tissue-Engineered Cardiomyocyte Sheets Enhances Neovascularization and Improves Cardiac Function of Ischemic Hearts Circulation, September 30, 2008; 118(14_suppl_1): S145 - S152. [Abstract] [Full Text] [PDF]

				D. Simpson, H. Liu, T.-H. M. Fan, R. Nerem, and S. C. Dudley Jr. A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling Stem Cells, September 1, 2007; 25(9): 2350 - 2357. [Abstract] [Full Text] [PDF]

				L. W. van Laake, R. Hassink, P. A. Doevendans, and C. Mummery Heart repair and stem cells J. Physiol., December 1, 2006; 577(2): 467 - 478. [Abstract] [Full Text] [PDF]

				K. H. Wu, Y. L. Liu, B. Zhou, and Z. C. Han Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 770 - 781. [Abstract] [Full Text] [PDF]

				K. L. Christman and R. J. Lee Biomaterials for the Treatment of Myocardial Infarction J. Am. Coll. Cardiol., September 5, 2006; 48(5): 907 - 913. [Abstract] [Full Text] [PDF]

				I. Kutschka, I. Y. Chen, T. Kofidis, T. Arai, G. von Degenfeld, A. Y. Sheikh, S. L. Hendry, J. Pearl, G. Hoyt, R. Sista, et al. Collagen Matrices Enhance Survival of Transplanted Cardiomyoblasts and Contribute to Functional Improvement of Ischemic Rat Hearts Circulation, July 4, 2006; 114(1_suppl): I-167 - I-173. [Abstract] [Full Text] [PDF]

				T. Eschenhagen and W. H. Zimmermann Engineering Myocardial Tissue Circ. Res., December 9, 2005; 97(12): 1220 - 1231. [Abstract] [Full Text] [PDF]